BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Lilly Development Centre

Below is an extended Lilly Development Centre research listing. Click here to return to the Lilly Development Centre main Biocorporate entry.

Recent Publications by Lilly Development Centre:

Comparison of liquid chromatography and capillary electrophoresis methods for quantification of sodium residuals.
Liquid chromatography (LC) and capillary electrophoresis (CE) methods were...
4th October, 2007
Lilly Development Centre, Analytical Sciences R&D, Rue Granbonpre 11, J Pharm Biomed Anal. 2007 Jul 27;44(3):615-22. Epub 2006 Aug 22.
DOI Direct Link
A new validation approach applied to the GC determination of impurities in organic solvents.
Organic solvents such as methanol, acetone, dichloromethane or toluene are...
14th March, 2007
Lilly Development Centre, Analytical Sciences R&D, rue Granbonpre 11, J Pharm Biomed Anal. 2006 Feb 13;40(2):294-304. Epub 2005 Sep 6.
DOI Direct Link
Synthesis of a peroxime proliferator activated receptor (PPAR) alpha/gamma agonist via stereocontrolled Williamson ether synthesis and stereospecific SN2 reaction of S-2-chloro propionic acid with phenoxides.
The stereospecific synthesis of the PPAR alpha/gamma agonist 1 was...
14th July, 2005
Chemical Product Research and Development, Lilly Development Centre, rue J Org Chem. 2005 Jun 10;70(12):4695-705.
DOI Direct Link
Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
Presently, the Caco-2 cell culture model is widely used during drug...
6th August, 2004
Biopharmaceutics & Drug Delivery, Lilly Development Centre, 11 rue Int J Pharm. 2004 Apr 15;274(1-2):221-32.
DOI Direct Link
An analysis of the SFSTP guide on validation of chromatographic bioanalytical methods: progress and limitations.
The Societe Francaise des Sciences et Techniques Pharmaceutiques (SFSTP)...
14th April, 2004
Lilly Development Centre, Statistical and Mathematical Sciences, rue J Pharm Biomed Anal. 2003 Aug 8;32(4-5):753-65.
Biological, pharmaceutical, and analytical considerations with respect to the transport media used in the absorption screening system, Caco-2.
During the evaluation and selection of drug candidates, the Caco-2 cell...
8th April, 2004
Biopharmaceutics and Drug Delivery, Lilly Development Centre, 11 rue J Pharm Sci. 2003 Aug;92(8):1545-58.
DOI Direct Link
Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolites.
BACKGROUND AND OBJECTIVES: Atomoxetine is a treatment for...
21st March, 2003
Department of Clinical Pharmacology, Lilly Research Laboratories, Lilly Clin Pharmacol Ther. 2003 Mar;73(3):178-91.
DOI Direct Link
Implementation of the caco-2 cell culture model as a predictive tool for the oral absorption of drugs. In-house evaluation procedures.
The Caco-2 cell culture model is widely used during drug development and...
18th March, 2003
Biopharmaceutics & Drug Delivery, Lilly Development Centre, J Pharm Belg. 2002 Nov-Dec;57(6):153-8.

«Lilly Development Centre

This page contained an extended Lilly Development Centre research listing. Click here to return to the Lilly Development Centre main Biocorporate entry.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.